The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.

Karen Mullan

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{3932624f199343feb8ed23891efcf81c,

title = "The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.",

author = "Karen Mullan",

year = "2006",

month = may,

doi = "10.1111/j.1365-2265.2006.02501.x",

language = "English",

volume = "64(5)",

pages = "519--522",

journal = "Clinical Endocrinology",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.

AU - Mullan, Karen

PY - 2006/5

Y1 - 2006/5

UR - http://www.scopus.com/inward/record.url?scp=33645986967&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.2006.02501.x

DO - 10.1111/j.1365-2265.2006.02501.x

M3 - Article

C2 - 16649970

VL - 64(5)

SP - 519

EP - 522

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 5

ER -